BHC
Bausch Health·NYSE
--
--(--)
--
--(--)
5.52 / 10
Netural
Fund flow is strong (7.74/10) with positive inflow ratios, yet all size categories show negative trends. Analyst coverage is minimal, only one neutral rating from Barclays, offering no clear conviction. Capital is entering, but sentiment remains lukewarm.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Glen SantangeloNeutral
Date2026-02-25
InstitutionBarclays
Times predicted2
Historical Win Rate50.0%
What is the analyst consensus for BHC?
- BHC holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.52/10 (Netural).
